Back to search

The Role of Cholesterol and Statins in Alzheimer's Disease

Data up to Jan 2025

Published2003
Citations66
References39

Total Citations Per Year

Abstract

References (39)

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

1993 • 8,888 citations

Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease

1993 • 3,693 citations

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1998 • 1,795 citations

Statins and the risk of dementia

2000 • 1,741 citations

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

2000 • 1,415 citations

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1997 • 1,380 citations

Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons

1998 • 1,139 citations

Drug Treatment of Lipid Disorders

1999 • 863 citations

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

1999 • 777 citations

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

1995 • 759 citations

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

1998 • 669 citations

Vascular risk factors for Alzheimer’s disease:

2000 • 657 citations

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.

1996 • 642 citations

Apolipoprotein E ϵ4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease

2002 • 630 citations

Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People

2002 • 519 citations

Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation

1998 • 508 citations

Serum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women

2002 • 432 citations

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial

2002 • 417 citations

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

2000 • 374 citations

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease

1995 • 372 citations

New Perspectives on Alzheimer's Disease

1986 • 349 citations

The importance of inflammatory mechanisms in alzheimer disease

1998 • 325 citations

Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E

1995 • 255 citations

The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system

1993 • 251 citations

Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1–Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation

2001 • 238 citations

The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment

2002 • 189 citations

Association between high‐density lipoprotein and cognitive impairment in the oldest old

2002 • 184 citations

Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid

2002 • 168 citations

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

1997 • 168 citations

ALZHEIMER'S DISEASE AND RELATED DISORDERS

2001 • 158 citations

Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia

2002 • 152 citations

Clinical Diagnosis and Management of Alzheimer's Disease

2006 • 145 citations

Plasma 24S-hydroxycholesterol

2000 • 140 citations

Removal of cholesterol from extrahepatic sources by oxidative mechanisms

1999 • 133 citations

HMG-CoA reductase inhibitors (statins)

2000 • 114 citations

Association between Alzheimer's disease and theNOS3 gene

1999 • 98 citations

High Density Lipoprotein Inhibits Assembly of Amyloid β-Peptides into Fibrils

2000 • 71 citations

Aberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration

2000 • 58 citations

Apolipoprotein E Genotype and Lipid and Lipoprotein Levels in Dementia

2000 • 38 citations

Cited By (0)

Loading...